meldepliktige handler fra primærinnsidere

← Alle transaksjoner

Management and key personnel in Medistim ASA purchases shares

Medistim ASA (MEDI) · publisert 20. juni 2025 kl. 10:41 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Medistim ASA disposal18 874161,6 NOK20. juni 2025llm
Thomas Jakobsen CFOacquisition2 475161,6 NOK20. juni 2025llm
H ege Wetterhus VP marketingacquisition619161,6 NOK20. juni 2025llm
Ole Arne Eiksund Chief Business Development Officeracquisition1 856161,6 NOK20. juni 2025llm
H kon Gr ther VP Innovationacquisition1 856161,6 NOK20. juni 2025llm
Anders Wangensten Team leader HWacquisition1 856161,6 NOK20. juni 2025llm
Robert Hurry Tech leadacquisition1 856161,6 NOK20. juni 2025llm
Tore Skjeggestad Business and product manager for Cardiacacquisition1 856161,6 NOK20. juni 2025llm
Andre Hagen Business and product manager for Vascularacquisition1 856161,6 NOK20. juni 2025llm
Kjersti Johansen Medical advisoracquisition1 856161,6 NOK20. juni 2025llm
Espen Bj sn s Finance manageracquisition1 856161,6 NOK20. juni 2025llm
Jonas Crosby Team leader SWacquisition928161,6 NOK20. juni 2025llm

Meldingstekst

Management and key personnel in Medistim ASA have the 20th of June purchased shares form Medistim ASA. This is part of the company long term incentive plan approved by the general meeting the 8th of May 2025. Price per share was NOK 161,60. The following members of management and key personnel have purchased shares: VP marketing Hæge Wetterhus purchased 619 shares and has 2210 shares after the purchase. Chief Business Development Officer Ole Arne Eiksund purchased 1856 shares and has 7728 shares after the purchase. VP Innovation Håkon Grøthe purchased 1856 shares and has 9677shares after the purchase. Team leader SW Jonas Crosby purchased 928 shares and has 928 shares after the purchase. Team leader HW Anders Wangensten purchased 1856 shares and has 1856 shares after the purchase. Tech lead Robert Hurry purchased 1856 shares and has 1856 shares after the purchase. Business and product manager for Cardiac Tore Skjeggestad purchased 1856 shares and has 1856 shares after the purchase. Business and product manager for Vascular Andre Hagen purchased 1856 shares and has 1856 shares after the purchase. Medical advisor Kjersti Johansen purchased 1856 shares and has 1856 shares after the purchase. Finance manager Espen Bjørsnøs purchased 1856 shares and has 1856 shares after the purchase. CFO Thomas Jakobsen purchased 2475 shares and has 33001 shares after the purchase. Medistim ASA sold 18874 shares and has 74243 own shares after the sale.